Literature DB >> 29335628

Endothelial cell damage in idiopathic pneumonia syndrome.

Thomas Altmann1, James Slack1, Mary A Slatter1, Christopher O'Brien2, Andrew Cant1, Matthew Thomas2, Malcolm Brodlie1, Srinivas Annavarapu2, Andrew R Gennery3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29335628     DOI： 10.1038/s41409-017-0042-z

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies.

Authors:  Eleonora Calabretta; Jose M Moraleda; Massimo Iacobelli; Ruben Jara; Israel Vlodavsky; Peter O'Gorman; Antonio Pagliuca; Clifton Mo; Rebecca M Baron; Alessio Aghemo; Robert Soiffer; Jawed Fareed; Carmelo Carlo-Stella; Paul Richardson
Journal:  Br J Haematol       Date:  2021-02-04       Impact factor: 6.998

2.  Successful ruxolitinib administration for a patient with steroid-refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: A case report and literature review.

Authors:  Dan Tomomasa; Takeshi Isoda; Noriko Mitsuiki; Motoi Yamashita; Aoi Morishita; Takahiro Tomoda; Tsubasa Okano; Akifumi Endo; Takahiro Kamiya; Masakatsu Yanagimachi; Kohsuke Imai; Hirokazu Kanegane; Masatoshi Takagi; Tomohiro Morio
Journal:  Clin Case Rep       Date:  2021-12-22

Review 3.  Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology.

Authors:  Giuseppe Milone; Claudia Bellofiore; Salvatore Leotta; Giulio Antonio Milone; Alessandra Cupri; Andrea Duminuco; Bruno Garibaldi; Giuseppe Palumbo
Journal:  J Clin Med       Date:  2022-01-26       Impact factor: 4.241

4.  Single-Cell Chromatin Accessibility Data Combined with GWAS Improves Detection of Relevant Cell Types in 59 Complex Phenotypes.

Authors:  Akash Chandra Das; Aidin Foroutan; Brian Qian; Nader Hosseini Naghavi; Kayvan Shabani; Parisa Shooshtari
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.